Photo by sammiechaffin from unsplash
Tumour necrosis factor-alpha inhibitors (TNFi) increase the risk of reactivation of latent tuberculosis (TB). The objective of this review was to assess the risk of tuberculosis in patients receiving TNFi… Click to show full abstract
Tumour necrosis factor-alpha inhibitors (TNFi) increase the risk of reactivation of latent tuberculosis (TB). The objective of this review was to assess the risk of tuberculosis in patients receiving TNFi therapy and to compare the risks among the different anti-TNF agents. We searched the
Keywords:
necrosis factor;
risk;
risk tuberculosis;
tuberculosis;
tumour necrosis
Journal Title: Clinical Medicine
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Medicine
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!